Retraction

Tanshinone IIA inhibits HIF-1α and VEGF expression in breast cancer cells via mTOR/p70S6K/RPS6/4E-BP1 signaling pathway

Citations (92)

92
Total Citations
1
Post-Retraction
(1.1%)
90
Pre-Retraction
1
Same Day
Post-Retraction Citation Analysis
0 Within 30 days
1 Within 1 year
0 After 2+ years
52 Days since retraction (latest)
Monitoring the Early Response of Fulvestrant Plus Tanshinone IIA Combination Therapy to Estrogen Receptor-Positive Breast Cancer by Longitudinal <sup>18</sup>F-FES PET/CT
Simin He, Mingwei Wang, Yongping Zhang et al. (5 authors)
Contrast Media & Molecular Imaging Open Access
Published: Jun 2019
8 citations
2111 days before retraction
Silencing PDK1 limits hypoxia‑induced pulmonary arterial hypertension in mice via the Akt/p70S6K signaling pathway
Ruo‐Min Di, Zhongzhou Yang, Peng Xu et al. (4 authors)
Experimental and Therapeutic Medicine Open Access
Published: May 2019
19 citations
2123 days before retraction
Vanillic Acid Suppresses HIF-1α Expression via Inhibition of mTOR/p70S6K/4E-BP1 and Raf/MEK/ERK Pathways in Human Colon Cancer HCT116 Cells
Gong Jing-li, Shengxue Zhou, Shihai Yang
International Journal of Molecular Sciences Open Access
Published: Jan 2019
102 citations
2250 days before retraction
Pro‐Angiogenic and Anti‐Angiogenic Effects of Small Molecules from Natural Products
Jingyi Ma, Xuelin Zhou
Unknown Journal
Published: Dec 2018
1 citation
2275 days before retraction
Tanshinone II A improves distribution and anti-tumor efficacy of pegylated liposomal doxorubicin via normalizing the structure and function of tumor vasculature in hepa1-6 hepatoma mice model
Ying Zhang, Tie Minghui, Feng Bi et al. (4 authors)
Deleted Journal Open Access
Published: Dec 2018
7 citations
2302 days before retraction
Vandetanib (ZD6474) induces antiangiogenesis through mTOR&amp;ndash;HIF-1 alpha&amp;ndash;VEGF signaling axis in breast cancer cells
Ling Li, Jing-kui Yu, Shuhong Jiao et al. (6 authors)
OncoTargets and Therapy Open Access
Published: Nov 2018
23 citations
2332 days before retraction
HGK-sestrin 2 signaling-mediated autophagy contributes to antitumor efficacy of Tanshinone IIA in human osteosarcoma cells
Jia-Hau Yen, Sheng‐Teng Huang, Hung-Sen Huang et al. (7 authors)
Cell Death and Disease Open Access
Published: Sep 2018
49 citations
2368 days before retraction
Tanshinone IIA Attenuates Insulin Like Growth Factor 1 -Induced Cell Proliferation in PC12 Cells through the PI3K/Akt and MEK/ERK Pathways
Haitao Wang, Xiaoying Su, Jiankang Fang et al. (10 authors)
International Journal of Molecular Sciences Open Access
Published: Sep 2018
22 citations
2382 days before retraction
Tanshinone IIA inhibits cell proliferation and tumor growth by downregulating STAT3 in human gastric cancer
Yongjun Zhang, Shuguang Guo, Jian‐Hong Fang et al. (6 authors)
Experimental and Therapeutic Medicine Open Access
Published: Aug 2018
39 citations
2423 days before retraction
Targeting VEGF/VEGFRs Pathway in the Antiangiogenic Treatment of Human Cancers by Traditional Chinese Medicine
Cheng Zhang, Ning Wang, Hor‐Yue Tan et al. (6 authors)
Integrative Cancer Therapies Open Access
Published: May 2018
29 citations
2489 days before retraction
MiR-429 Regulated by Endothelial Monocyte Activating Polypeptide-II (EMAP-II) Influences Blood-Tumor Barrier Permeability by Inhibiting the Expressions of ZO-1, Occludin and Claudin-5
Liangyu Chen, Yixue Xue, Jian Zheng et al. (12 authors)
Frontiers in Molecular Neuroscience Open Access
Published: Feb 2018
23 citations
2600 days before retraction
Hypoxia-Inducible Factor 1α Regulates the Transforming Growth Factor β1/SMAD Family Member 3 Pathway to Promote Breast Cancer Progression
Jianheng Peng, Xiaolin Wang, Ran Liang et al. (6 authors)
Journal of Breast Cancer Open Access
Published: Jan 2018
37 citations
2636 days before retraction
Tanshinone I prevents atorvastatin-induced cerebral hemorrhage in zebrafish and stabilizes endothelial cell–cell adhesion by inhibiting VE-cadherin internalization and actin-myosin contractility
Bin Huang, Zhong-Yan Zhou, Li Shang et al. (7 authors)
Pharmacological Research
Published: Oct 2017
28 citations
2717 days before retraction
Tanshinone IIA Inhibits VEGF Secretion and HIF-1α Expression in Cultured Human Retinal Pigment Epithelial Cells under Hypoxia
Rami M. Alzhrani, Qasim Alhadidi, Rinda Devi Bachu et al. (6 authors)
Current Eye Research Open Access
Published: Sep 2017
19 citations
2737 days before retraction
Tanshinone IIA attenuates nerve transection injury associated with nerve regeneration promotion in rats
Li Mo, Jingyi Wang, Lixiang Ding et al. (6 authors)
Neuroscience Letters Open Access
Published: Aug 2017
12 citations
2759 days before retraction
Participación de HIF-1 en la regulación de la autofagia inducida farmacológicamente en células tumorales de mama y de colon
Rebeca Salgado García
Unknown Journal Open Access
Published: Aug 2017
2761 days before retraction
Neocortical developmental analysis of vasculature and their growth factors offer new insight into fragile X syndrome abnormalities
Amogh P. Belagodu, Stephen A. Fleming, Roberto Galvez
Developmental Neurobiology
Published: Jul 2017
6 citations
2803 days before retraction
Effects of bufalin on the mTOR/p70S6K pathway and apoptosis in esophageal squamous cell carcinoma in nude mice
Yao Liu, Xu Wang, Ying Jia et al. (4 authors)
International Journal of Molecular Medicine Open Access
Published: Jun 2017
13 citations
2828 days before retraction
Tanshinone IIA inhibits β-catenin/VEGF-mediated angiogenesis by targeting TGF-β1 in normoxic and HIF-1α in hypoxic microenvironments in human colorectal cancer
Hua Sui, Jihui Zhao, Lihong Zhou et al. (13 authors)
Cancer Letters
Published: Jun 2017
150 citations
2844 days before retraction
Site-selective Csp 3 -H aryloxylation of natural product Tanshinone IIA and its analogues
Bing Liang, Shujuan Yu, Jie Li et al. (7 authors)
Tetrahedron Letters
Published: Mar 2017
12 citations
2915 days before retraction
Paper citing Tanshinone IIA inhibits HIF-1α and VEGF expression...
Unknown Authors
Unknown Journal
Published: Mar 2017
2915 days before retraction
Anti-cancer effect of danshen and dihydroisotanshinone I on prostate cancer: targeting the crosstalk between macrophages and cancer cells via inhibition of the STAT3/CCL2 signaling pathway
Ching-Yuan Wu, Yao‐Hsu Yang, Yin-Yin Lin et al. (14 authors)
Oncotarget Open Access
Published: Feb 2017
53 citations
2970 days before retraction
Tanshinone IIA induces intrinsic apoptosis in osteosarcoma cells both in vivo and in vitro associated with mitochondrial dysfunction
Sheng‐Teng Huang, Chao-Chun Huang, Wen‐Liang Huang et al. (8 authors)
Scientific Reports Open Access
Published: Jan 2017
40 citations
2982 days before retraction
Anticancer Activity of Salvia miltiorrhiza and Its Secondary Metabolites
Ching‐Fen Wu, Thomas Efferth
Springer eBooks
Published: Jan 2017
2 citations
3001 days before retraction
MiR-129-5p Sensitizes the Response of Her-2 Positive Breast Cancer to Trastuzumab by Reducing Rps6
Xiangdong Lu, Jingjing Ma, Jiahui Chu et al. (12 authors)
Cellular Physiology and Biochemistry Open Access
Published: Jan 2017
37 citations
3001 days before retraction
Tanshinone IIA combined with adriamycin inhibited malignant biological behaviors of NSCLC A549 cell line in a synergistic way
Jun Xie, Jiahui Liu, Heng Liu et al. (11 authors)
BMC Cancer Open Access
Published: Nov 2016
54 citations
3045 days before retraction
Catalyst-Free sp<sup>3</sup> C–H Acyloxylation: Regioselective Synthesis of 1-Acyloxy Derivatives of the Natural Product Tanshinone IIA
Chunyong Ding, Jie Li, Mingkun Jiao et al. (4 authors)
Journal of Natural Products
Published: Sep 2016
23 citations
3097 days before retraction
Blocking elevated VEGF‐A attenuates non‐vasculature Fragile X syndrome abnormalities
Amogh P. Belagodu, Liridon Zendeli, Bernard J. Slater et al. (4 authors)
Developmental Neurobiology Open Access
Published: Jun 2016
13 citations
3210 days before retraction
Anticancer potential of Salvia miltiorrhiza and its tanshinones: an efficacy perspective
Junxuan Lü, Wei Wu, Yong Zhang et al. (6 authors)
Botanics Targets and Therapy Open Access
Published: Apr 2016
4 citations
3276 days before retraction
Paper citing Tanshinone IIA inhibits HIF-1α and VEGF expression...
Unknown Authors
Unknown Journal
Published: Mar 2016
3280 days before retraction
eIF4E-phosphorylation-mediated Sox2 upregulation promotes pancreatic tumor cell repopulation after irradiation
Yang Yu, Ling Tian, Feng Xiao et al. (11 authors)
Cancer Letters
Published: Mar 2016
25 citations
3306 days before retraction
Proteome-Wide Effect of 17-β-Estradiol and Lipoxin A4 in an Endometriotic Epithelial Cell Line
Jonathan Sobel, Patrice Waridel, Ilaria Gori et al. (5 authors)
Frontiers in Endocrinology Open Access
Published: Jan 2016
3 citations
3362 days before retraction
The interplay between autophagy and apoptosis induced by tanshinone IIA in prostate cancer cells
Chunlong Li, Xiancheng Han, Hong Zhang et al. (5 authors)
Tumor Biology
Published: Dec 2015
32 citations
3378 days before retraction
A promising “TRAIL” of tanshinones for cancer therapy
Tsing-Fen Ho, Chia‐Che Chang
Biomedicine Open Access
Published: Nov 2015
20 citations
3401 days before retraction
Theaflavin-3, 3′-digallate decreases human ovarian carcinoma OVCAR-3 cell-induced angiogenesis via Akt and Notch-1 pathways, not via MAPK pathways
Ying Gao, Gary O. Rankin, Youying Tu et al. (4 authors)
International Journal of Oncology Open Access
Published: Nov 2015
76 citations
3409 days before retraction
Tanshinone IIA inhibits acute promyelocytic leukemia cell proliferation and induces their apoptosis in vivo
Kaiji Zhang, Jian Li, Wentong Meng et al. (5 authors)
Blood Cells Molecules and Diseases
Published: Oct 2015
28 citations
3430 days before retraction
<i>In vitro</i> anti-tumor activity of the tanshinone IIA against SKOV3 cells
Ju Huang, Hao Lin, Ying‐Kai Hong
Natural Product Research Open Access
Published: Aug 2015
8 citations
3514 days before retraction
Tanshinone IIA Facilitates TRAIL Sensitization by Up-regulating DR5 through the ROS-JNK-CHOP Signaling Axis in Human Ovarian Carcinoma Cell Lines
Chia‐Che Chang, Cheng‐Ping Kuan, Jyun-Yi Lin et al. (5 authors)
Chemical Research in Toxicology
Published: Jul 2015
51 citations
3529 days before retraction
Inhibition of Mammalian Target of Rapamycin Complex 1 (mTORC1) Downregulates ELOVL1 Gene Expression and Fatty Acid Synthesis in Goat Fetal Fibroblasts
Weipeng Wang, Qiburi He, Zhixin Guo et al. (9 authors)
International Journal of Molecular Sciences Open Access
Published: Jul 2015
14 citations
3532 days before retraction
Tanshinone IIA enhances the effects of TRAIL by downregulating survivin in human ovarian carcinoma cells
Jyun-Yi Lin, Yumin Ke, Jui-Sheng Lai et al. (4 authors)
Phytomedicine
Published: Jul 2015
23 citations
3543 days before retraction
Immunohistochemical analysis of phosphorylated mammalian target of rapamycin and its downstream signaling components in invasive breast cancer
Binlin Ma, Meihui Shan, Gang Sun et al. (7 authors)
Molecular Medicine Reports Open Access
Published: Jul 2015
12 citations
3549 days before retraction
Renal Toxicities of Targeted Therapies
Anum Abbas, Mohsin Mirza, Jcm Ho et al. (4 authors)
Targeted Oncology
Published: Apr 2015
85 citations
3614 days before retraction
Related Records

This article has multiple records in the database due to different notices:

Record #64720
May 12, 2025
Correction
Quick Stats
Total Citations: 92
Years Since Retraction: <1 year
Open Access: Yes
Last Checked: Jul 23, 2025